Statement on hepatitis vaccines for travellers. An Advisory Committee Statement (ACS).
D002170:Canada; D003906:Developing Countries; D006506:Hepatitis A / Q000517:prevention & control; D022362:Hepatitis A Vaccines / Q000627:therapeutic use; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006526:Hepatitis C / Q000517:prevention & control; D016751:Hepatitis E / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000517:prevention & control*; D006801:Humans; D014195:Travel; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines